...
nwbo-img

Northwest Biotherapeutics Inc, Common Stock

NWBO

PNK

$0.28

-$0.02

(-6.67%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$376.26M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
3.55M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.56
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.24 L
$0.86 H
$0.28

About Northwest Biotherapeutics Inc, Common Stock

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameNWBOSectorS&P500
1-Week Return-0.68%-1.8%-0.77%
1-Month Return-13.09%-3.48%0.71%
3-Month Return-10.29%-7.2%8.81%
6-Month Return-38.2%-1.54%12.32%
1-Year Return-61.9%8.39%30.57%
3-Year Return-59.7%6.07%29.21%
5-Year Return27.57%44.07%91.95%
10-Year Return-94.37%106.3%196.04%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue2.41M1.29M1.00M1.68M1.93M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":53.57,"profit":true},{"date":"2021-12-31","value":41.7,"profit":true},{"date":"2022-12-31","value":69.83,"profit":true},{"date":"2023-12-31","value":80.17,"profit":true}]
Cost of Revenue29.87M87.90M53.71M--[{"date":"2019-12-31","value":33.99,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":61.1,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit(27.46M)(86.61M)(52.70M)--[{"date":"2019-12-31","value":-2746300000,"profit":false},{"date":"2020-12-31","value":-8660500000,"profit":false},{"date":"2021-12-31","value":-5270200000,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin(1139.54%)(6708.37%)(5243.98%)--[{"date":"2019-12-31","value":-1139.54,"profit":false},{"date":"2020-12-31","value":-6708.37,"profit":false},{"date":"2021-12-31","value":-5243.98,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses29.87M87.90M53.71M68.86M57.44M[{"date":"2019-12-31","value":33.99,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":61.1,"profit":true},{"date":"2022-12-31","value":78.35,"profit":true},{"date":"2023-12-31","value":65.35,"profit":true}]
Operating Income(27.46M)(86.61M)(52.70M)(67.18M)(55.51M)[{"date":"2019-12-31","value":-2746300000,"profit":false},{"date":"2020-12-31","value":-8660500000,"profit":false},{"date":"2021-12-31","value":-5270200000,"profit":false},{"date":"2022-12-31","value":-6718100000,"profit":false},{"date":"2023-12-31","value":-5550800000,"profit":false}]
Total Non-Operating Income/Expense7.17M(443.22M)231.83M(37.85M)(7.09M)[{"date":"2019-12-31","value":3.09,"profit":true},{"date":"2020-12-31","value":-191.18,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-16.33,"profit":false},{"date":"2023-12-31","value":-3.06,"profit":false}]
Pre-Tax Income(20.30M)(529.82M)179.13M(105.03M)(62.60M)[{"date":"2019-12-31","value":-11.33,"profit":false},{"date":"2020-12-31","value":-295.78,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-58.64,"profit":false},{"date":"2023-12-31","value":-34.95,"profit":false}]
Income Taxes-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(20.30M)(529.82M)179.13M(105.03M)(62.60M)[{"date":"2019-12-31","value":-11.33,"profit":false},{"date":"2020-12-31","value":-295.78,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-58.64,"profit":false},{"date":"2023-12-31","value":-34.95,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(20.30M)(529.82M)179.13M(105.03M)(62.60M)[{"date":"2019-12-31","value":-11.33,"profit":false},{"date":"2020-12-31","value":-295.78,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-58.64,"profit":false},{"date":"2023-12-31","value":-34.95,"profit":false}]
EPS (Diluted)(0.05)(0.76)0.19(0.10)(0.06)[{"date":"2019-12-31","value":-27.03,"profit":false},{"date":"2020-12-31","value":-404.45,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-51.14,"profit":false},{"date":"2023-12-31","value":-30.21,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

NWBO
Current Ratio 0.09

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NWBO
ROA (LTM) -137.16%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NWBO
Debt Ratio Lower is generally better. Negative is bad. 3.71
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -2.71

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NWBO
Trailing PE NM
Forward PE NM
P/S (TTM) 222.27
P/B 0.00
Price/FCF NM
EV/R 274.04
EV/Ebitda NM
PEG NM

FAQs

What is Northwest Biotherapeutics Inc share price today?

Northwest Biotherapeutics Inc (NWBO) share price today is $0.28

Can Indians buy Northwest Biotherapeutics Inc shares?

Yes, Indians can buy shares of Northwest Biotherapeutics Inc (NWBO) on Vested. To buy Northwest Biotherapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NWBO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Northwest Biotherapeutics Inc be purchased?

Yes, you can purchase fractional shares of Northwest Biotherapeutics Inc (NWBO) via the Vested app. You can start investing in Northwest Biotherapeutics Inc (NWBO) with a minimum investment of $1.

How to invest in Northwest Biotherapeutics Inc shares from India?

You can invest in shares of Northwest Biotherapeutics Inc (NWBO) via Vested in three simple steps:

  • Click on Sign Up or Invest in NWBO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Northwest Biotherapeutics Inc shares
What is Northwest Biotherapeutics Inc 52-week high and low stock price?

The 52-week high price of Northwest Biotherapeutics Inc (NWBO) is $0.86. The 52-week low price of Northwest Biotherapeutics Inc (NWBO) is $0.24.

What is Northwest Biotherapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Northwest Biotherapeutics Inc (NWBO) is

What is Northwest Biotherapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Northwest Biotherapeutics Inc (NWBO) is 0.00

What is Northwest Biotherapeutics Inc dividend yield?

The dividend yield of Northwest Biotherapeutics Inc (NWBO) is 0.00%

What is the Market Cap of Northwest Biotherapeutics Inc?

The market capitalization of Northwest Biotherapeutics Inc (NWBO) is $376.26M

What is Northwest Biotherapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Northwest Biotherapeutics Inc is NWBO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top